BackgroundTreating severe pneumonia caused by multiple pathogens in immunocompromised hosts (ICHs) presents significant challenges. Isavuconazole (ISA). a next-generation triazole antifungal agent. has shown promise in managing fungal infections. https://macorners.shop/product-category/christmas-card/